Praxis Biotech is a US-based Drug Discovery company focused on bringing promising medical technologies from the research laboratory to the patient’s bedside. The company has developed a portfolio of active molecules for diagnostic and therapeutic applications in cancer, aging, and fibrosis. These programs focus on modulating FAP proteins (Fibroblast Activation Protein) to address various medical challenges.